Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2305-2310

  Hanari, Naoyuki ^a   Matsubara, Hisahiro ^a   Hoshino, Isamu ^a   Akutsu, Yasunori ^a   Nishimori, Takanori ^a   Murakami, Kenataro ^a   Sakata, Haruhito ^a   Miyazawa, Yukimasa ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Combinatory gene therapy; Electroporation; HSV TK; Interleukin 21

Indexed keywords

DNA; GANCICLOVIR; INTERLEUKIN 21; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTRIC POTENTIAL; ELECTROPORATION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY ANALYSIS; SUICIDE GENE; SUICIDE GENE THERAPY; T CELL DEPLETION; TRANSCRIPTION INITIATION; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DNA; ELECTROPORATION; ESOPHAGEAL NEOPLASMS; GANCICLOVIR; GENE THERAPY; HUMANS; INTERLEUKINS; MICE; MICE, INBRED BALB C; PROMOTER REGIONS (GENETICS); SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

EID: 34547738045     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hurt R: Surgical treatment of carcinoma of the esophagus. Thorax 46: 526-535, 1991.
2. Kato H: Diagnosis and treatment of esophageal neoplasm. Jpn J Cancer Res 86: 993-1009, 1995.
3. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL and Abraham GN: The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283, 1993.
4. Freeman SM, Ramesh R and Marrogi AJ: Immune system in suicide-gene therapy. Lancet 349: 2-3, 1997.
5. Majumdar AS, Zolotorev A, Samuel S, Tran K, Vertin B, Hall-Meier M, Antoni B-A, Adeline E, Philip M and Philip R: Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model. Cancer Gene Ther 7: 1086-1099, 2000.
6. Lechanteur C, Delvenne P, Princen F, Lopez M, Fillet G, Gielen J, Merville M-P and Bours V: Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut 47: 343-348, 2000.
7. Freund C, Sutton M, Dang T, Contant C, Rowley D and Lerner S: Adenovirus-mediated combination suicide gene and cytokine gene therapy for bladder cancer. Anticancer Res 20: 1359-1366, 2000.
8. Parrish-Novok J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West J, Schrader S, Burkhead S, Heipel M, Brandt C, Kuijper JL, Kramer J, Conklin D, Presnell SR, Berry J, Shiota F, Bort S, Hambly K, Mudri S, Clegg C, Moore M, Grant FJ, Lofton-Day C, Gilbert T, Rayond F, Ching A, Yao L, Smith D, Webster P, Whitmore T, Maurer M, Kaushansky K, Holly RD and Foster D: Interleukin-21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63, 2000.
9. Ozaki K, Kikly K, Michalovich D, Young PR and Leonard WJ: Cloning of type 1 cytokine receptor most related to the IL-2 receptor β chain. Proc Natl Acad Sci USA 97: 11439-11444, 2000.
10. Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek JS, Senices M, Konz RF, Wurster AL, Donaldson DD, Collins M, Young DA and Grusby MJ: IL-21 limits NK cell response and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569, 2002.
11. Ugai S, Shimozato O, Kawamura K, Wang YQ, Tamaguchi T, Saisho H, Sakiyama S and Tagawa M: Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther 10: 187-192, 2003.
12. Yoshida Y, Tomizawa M, Bahar R, Miyauchi M, Yamaguchi T, Saisho H, Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S and Tagawa M: A promoter region of midkine gene can activate transcription of an exogenous suicide gene therapy in human pancreatic cancer. Cancer Gene Ther 22: 117-120, 2002.
13. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC and Schabel FM Jr: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-2439, 1975.
14. Ebina T and Murata K: Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents. Jpn J Cancer Res 83: 775-782, 1992.
15. Miller AD and Rosman GJ: Improved retroviral vectors for gene transfer and expression. Bio Techniques 7: 980-990, 1989.
16. Janik P, Briand P and Hartmann NR: The effect of estone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res 35: 3698-3704, 1975.
17. Kadomatsu K, Tomomura M and Muramatsu T: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 1312-1318, 1988.
18. Kadomatsu K, Huang R, Suganuma T, Murata F and Muramatsu T: A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in a spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 110: 607-616, 1990.
19. Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y and Muramatsu T: A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 53: 1281-1285, 1993.
20. Garver RI Jr, Radford DM, Donis-Keller H, Wick MR and Milner PG: Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74: 1584-1590, 1994.
21. Miyauchi M, Shimada H, Kadomatsu K, Muramatsu T, Matsubara S, Ikematsu S, Takenaga K, Asano T, Ochiai T, Sakiyama S and Tagawa M: Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res 90: 469-475, 1999.
22. Maeda T, O-Wang J, Matsubara H, Asano T, Ochiai T, Sakiyama S and Tagawa M: A minimum c-erbB-2 promoter-mediated expression of herpes simplex thymidine kinase gene confers selective cytotoxicity of human cancer cells to ganciclovir. Cancer Gene Ther 8: 890-896, 2001.
23. Yoshida Y, Tomizawa M, Bahar R. Miyauchi M, Yamaguchi T, Saisho H. Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S, and Tagawa M: A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer. Anticancer Res 22: 117-120, 2002.
24. Rols MP, Delteil C, Golzio M, Dumand P, Cros S and Teissie J: In vivo electrically mediated protein and protein transfer in murine melanoma. Nat Biotech 16: 168-171, 1998.
25. Wells JM, Li LH, Jahreis GP and Hui SW: Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 7: 541-547, 2000.
26. Matsubara H, Gunji Y, Maeda T, Tasaki K, Koide Y, Asano T, Ochiai T, Sakiyama S and Tagawa M: Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effect in mice. Anticancer Res 21: 2501-2504, 2001.
27. Zinkernagel RM: Immunology taught by viruses. Science 271: 173-178, 1996.
28. Kozarsky KF and Wilson JM: Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3: 499-503, 1993.
29. Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI and Sugimachi K: Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 61: 1005-1012, 2001.